Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Do interventions that address patient cost-sharing improve adherence to prescription drugs? A systematic review of recently published studies.

Sensharma A, Yabroff KR.

Expert Rev Pharmacoecon Outcomes Res. 2019 Jan 10. doi: 10.1080/14737167.2019.1567335. [Epub ahead of print]

PMID:
30628493
2.

Costs of cancer along the care continuum: What we can expect based on recent literature.

Pisu M, Henrikson NB, Banegas MP, Yabroff KR.

Cancer. 2018 Nov 1;124(21):4181-4191. doi: 10.1002/cncr.31643. Epub 2018 Oct 17. Review.

PMID:
30475400
3.

Medical Financial Hardship among Cancer Survivors in the United States: What Do We Know? What Do We Need to Know?

Yabroff KR, Zhao J, Zheng Z, Rai A, Han X.

Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1389-1397. doi: 10.1158/1055-9965.EPI-18-0617. Epub 2018 Nov 14.

PMID:
30429132
4.

Comparison of Insurance Status and Diagnosis Stage Among Patients With Newly Diagnosed Cancer Before vs After Implementation of the Patient Protection and Affordable Care Act.

Han X, Yabroff KR, Ward E, Brawley OW, Jemal A.

JAMA Oncol. 2018 Dec 1;4(12):1713-1720. doi: 10.1001/jamaoncol.2018.3467.

PMID:
30422152
5.

ROLE OF CANCER HISTORY AND GENDER IN MAJOR HEALTH INSURANCE TRANSITIONS: A LONGITUDINAL NATIONALLY REPRESENTATIVE STUDY.

Virgo KS, Lin CC, Davidoff A, Guy GP Jr, de Moor JS, Ekwueme DU, Kent EE, Chawla N, Yabroff KR.

Res Sociol Health Care. 2018 Sep;36:59-84. doi: 10.1108/S0275-495920180000036003.

PMID:
30344360
6.

Patient and provider communication about employment following a cancer diagnosis.

de Moor JS, Coa K, Kent EE, Moten C, Kobrin S, Altice C, Yabroff KR.

J Cancer Surviv. 2018 Dec;12(6):813-820. doi: 10.1007/s11764-018-0718-4. Epub 2018 Oct 3.

PMID:
30284114
7.

Cost, Value, and Financial Hardship in Cancer Care: Implications for Pediatric Oncology.

Parsons SK, Castellino SM, Yabroff KR.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):850-860. doi: 10.1200/EDBK_200359. Review.

PMID:
30231364
8.

Determinants and Outcomes of Satisfaction With Healthcare Provider Communication Among Cancer Survivors.

Rai A, Han X, Zheng Z, Yabroff KR, Jemal A.

J Natl Compr Canc Netw. 2018 Aug;16(8):975-984. doi: 10.6004/jnccn.2018.7034.

PMID:
30099374
9.

The Long Shadow of Childhood Cancer: Lasting Risk of Medical Financial Hardship.

Zheng Z, Yabroff KR.

J Natl Cancer Inst. 2018 Aug 1. doi: 10.1093/jnci/djy122. [Epub ahead of print] No abstract available.

PMID:
30085202
10.

Financial Hardship and the Economic Effect of Childhood Cancer Survivorship.

Nathan PC, Henderson TO, Kirchhoff AC, Park ER, Yabroff KR.

J Clin Oncol. 2018 Jul 20;36(21):2198-2205. doi: 10.1200/JCO.2017.76.4431. Epub 2018 Jun 6.

PMID:
29874136
11.

Systematic review of healthcare costs related to mental health conditions among cancer survivors.

Khushalani JS, Qin J, Cyrus J, Buchanan Lunsford N, Rim SH, Han X, Yabroff KR, Ekwueme DU.

Expert Rev Pharmacoecon Outcomes Res. 2018 Oct;18(5):505-517. doi: 10.1080/14737167.2018.1485097. Epub 2018 Jun 20. Review.

12.

Impact of sociodemographic characteristics on underemployment in a longitudinal, nationally representative study of cancer survivors: Evidence for the importance of gender and marital status.

Kent EE, Davidoff A, de Moor JS, McNeel TS, Virgo KS, Coughlan D, Han X, Ekwueme DU, Guy GP Jr, Banegas MP, Alfano CM, Dowling EC, Yabroff KR.

J Psychosoc Oncol. 2018 May-Jun;36(3):287-303. doi: 10.1080/07347332.2018.1440274. Epub 2018 Apr 10.

PMID:
29634413
13.

Medical Care Costs Associated With Cancer in Integrated Delivery Systems.

Banegas MP, Yabroff KR, O'Keeffe-Rosetti MC, Ritzwoller DP, Fishman PA, Salloum RG, Lafata JE, Hornbrook MC.

J Natl Compr Canc Netw. 2018 Apr;16(4):402-410. doi: 10.6004/jnccn.2017.7065.

PMID:
29632060
14.

Trends in Financial Access to Prescription Drugs Among Cancer Survivors.

Gonzales F, Zheng Z, Yabroff KR.

J Natl Cancer Inst. 2018 Feb 1;110(2). doi: 10.1093/jnci/djx164.

15.

Association of Insurance Gains and Losses With Access to Prescription Drugs.

Yabroff KR, Kirby J, Zodet M.

JAMA Intern Med. 2017 Oct 1;177(10):1531-1532. doi: 10.1001/jamainternmed.2017.4011. No abstract available.

16.

Economic Burden of Chronic Conditions Among Survivors of Cancer in the United States.

Guy GP Jr, Yabroff KR, Ekwueme DU, Rim SH, Li R, Richardson LC.

J Clin Oncol. 2017 Jun 20;35(18):2053-2061. doi: 10.1200/JCO.2016.71.9716. Epub 2017 May 4.

17.

Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States.

Zheng Z, Han X, Guy GP Jr, Davidoff AJ, Li C, Banegas MP, Ekwueme DU, Yabroff KR, Jemal A.

Cancer. 2017 Apr 15;123(8):1453-1463. doi: 10.1002/cncr.30560. Epub 2017 Feb 20.

18.

Access to Cancer Care and General Medical Care Services Among Cancer Survivors in the United States: An Analysis of 2011 Medical Expenditure Panel Survey Data.

de Moor JS, Virgo KS, Li C, Chawla N, Han X, Blanch-Hartigan D, Ekwueme DU, McNeel TS, Rodriguez JL, Yabroff KR.

Public Health Rep. 2016 Nov;131(6):783-790. doi: 10.1177/0033354916675852. Epub 2016 Oct 27.

19.

Antineoplastic Treatment of Advanced-Stage Non-Small-Cell Lung Cancer: Treatment, Survival, and Spending (2000 to 2011).

Bradley CJ, Yabroff KR, Mariotto AB, Zeruto C, Tran Q, Warren JL.

J Clin Oncol. 2017 Feb 10;35(5):529-535. doi: 10.1200/JCO.2016.69.4166. Epub 2017 Jan 3.

20.

Annual Economic Burden of Productivity Losses Among Adult Survivors of Childhood Cancers.

Guy GP Jr, Berkowitz Z, Ekwueme DU, Rim SH, Yabroff KR.

Pediatrics. 2016 Nov;138(Suppl 1):S15-S21.

21.

Financial Hardships Experienced by Cancer Survivors: A Systematic Review.

Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR.

J Natl Cancer Inst. 2016 Oct 20;109(2). pii: djw205. Print 2017 Feb. Review.

22.

The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review.

Rim SH, Guy GP Jr, Yabroff KR, McGraw KA, Ekwueme DU.

Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):579-589. Epub 2016 Oct 6. Review.

23.

Use of High-cost Systemic Treatments in Elderly mCRC Patients.

Bradley CJ, Yabroff KR, Warren JL, Zeruto C, Chawla N, Lamont EB.

Med Care. 2017 Jan;55(1):86-87. No abstract available.

24.

Employment implications of informal cancer caregiving.

de Moor JS, Dowling EC, Ekwueme DU, Guy GP Jr, Rodriguez J, Virgo KS, Han X, Kent EE, Li C, Litzelman K, McNeel TS, Liu B, Yabroff KR.

J Cancer Surviv. 2017 Feb;11(1):48-57. doi: 10.1007/s11764-016-0560-5. Epub 2016 Jul 16.

25.

Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.

Banegas MP, Harlan LC, Mann B, Yabroff KR.

Urol Oncol. 2016 Oct;34(10):433.e9-433.e17. doi: 10.1016/j.urolonc.2016.05.021. Epub 2016 Jun 16.

26.

Quality of Patient-Provider Communication Among Cancer Survivors: Findings From a Nationally Representative Sample.

Chawla N, Blanch-Hartigan D, Virgo KS, Ekwueme DU, Han X, Forsythe L, Rodriguez J, McNeel TS, Yabroff KR.

J Oncol Pract. 2016 Dec;12(12):e964-e973. Epub 2016 Oct 31.

27.

Trends in the Treatment of Metastatic Colon and Rectal Cancer in Elderly Patients.

Bradley CJ, Yabroff KR, Warren JL, Zeruto C, Chawla N, Lamont EB.

Med Care. 2016 May;54(5):490-7. doi: 10.1097/MLR.0000000000000510.

PMID:
26900834
28.

For Working-Age Cancer Survivors, Medical Debt And Bankruptcy Create Financial Hardships.

Banegas MP, Guy GP Jr, de Moor JS, Ekwueme DU, Virgo KS, Kent EE, Nutt S, Zheng Z, Rechis R, Yabroff KR.

Health Aff (Millwood). 2016 Jan;35(1):54-61. doi: 10.1377/hlthaff.2015.0830.

29.

Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States.

Zheng Z, Yabroff KR, Guy GP Jr, Han X, Li C, Banegas MP, Ekwueme DU, Jemal A.

J Natl Cancer Inst. 2015 Dec 24;108(5). doi: 10.1093/jnci/djv382. Print 2016 May.

30.

Minimizing the "financial toxicity" associated with cancer care: advancing the research agenda.

Tucker-Seeley RD, Yabroff KR.

J Natl Cancer Inst. 2015 Dec 11;108(5). pii: djv410. doi: 10.1093/jnci/djv410. Print 2016 May. No abstract available.

PMID:
26657336
31.

Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors.

Yabroff KR, Dowling EC, Guy GP Jr, Banegas MP, Davidoff A, Han X, Virgo KS, McNeel TS, Chawla N, Blanch-Hartigan D, Kent EE, Li C, Rodriguez JL, de Moor JS, Zheng Z, Jemal A, Ekwueme DU.

J Clin Oncol. 2016 Jan 20;34(3):259-67. doi: 10.1200/JCO.2015.62.0468. Epub 2015 Dec 7.

32.

Healthcare Expenditure Burden Among Non-elderly Cancer Survivors, 2008-2012.

Guy GP Jr, Yabroff KR, Ekwueme DU, Virgo KS, Han X, Banegas MP, Soni A, Zheng Z, Chawla N, Geiger AM.

Am J Prev Med. 2015 Dec;49(6 Suppl 5):S489-97. doi: 10.1016/j.amepre.2015.09.002.

33.

An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data.

Bremner KE, Krahn MD, Warren JL, Hoch JS, Barrett MJ, Liu N, Barbera L, Yabroff KR.

Palliat Med. 2015 Dec;29(10):918-28. doi: 10.1177/0269216315596505. Epub 2015 Sep 1.

PMID:
26330452
34.

Cancer and quality of life in spousal dyads: spillover in couples with and without cancer-related health problems.

Litzelman K, Green PA, Yabroff KR.

Support Care Cancer. 2016 Feb;24(2):763-771. doi: 10.1007/s00520-015-2840-4. Epub 2015 Jul 5.

35.

The Affordable Care Act and Expanded Insurance Eligibility Among Nonelderly Adult Cancer Survivors.

Davidoff AJ, Hill SC, Bernard D, Yabroff KR.

J Natl Cancer Inst. 2015 Jul 1;107(9). pii: djv181. doi: 10.1093/jnci/djv181. Print 2015 Sep.

36.
37.

Challenges and opportunities in measuring cancer recurrence in the United States.

Warren JL, Yabroff KR.

J Natl Cancer Inst. 2015 May 12;107(8). pii: djv134. doi: 10.1093/jnci/djv134. Print 2015 Aug.

38.

Dependent coverage and use of preventive care under the Affordable Care Act.

Han X, Yabroff KR, Robbins AS, Zheng Z, Jemal A.

N Engl J Med. 2014 Dec 11;371(24):2341-2. doi: 10.1056/NEJMc1406586. No abstract available. Erratum in: N Engl J Med. 2015 Aug 20;373(8):782. Jamal, Ahmedin [corrected to Jemal, Ahmedin].

39.

Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011.

Guy GP Jr, Machlin SR, Ekwueme DU, Yabroff KR.

Am J Prev Med. 2015 Feb;48(2):183-187. doi: 10.1016/j.amepre.2014.08.036. Epub 2014 Nov 10.

40.

Renal cell cancer: a shift in approaches for treatment of advanced disease in the United States.

Banegas MP, Harlan LC, Mann B, Yabroff KR.

J Natl Compr Canc Netw. 2014 Sep;12(9):1271-9.

PMID:
25190695
41.

Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.

Chawla N, Yabroff KR, Mariotto A, McNeel TS, Schrag D, Warren JL.

Ann Epidemiol. 2014 Sep;24(9):666-72, 672.e1-2. doi: 10.1016/j.annepidem.2014.06.099. Epub 2014 Jul 3.

42.

Annual patient time costs associated with medical care among cancer survivors in the United States.

Yabroff KR, Guy GP Jr, Ekwueme DU, McNeel T, Rozjabek HM, Dowling E, Li C, Virgo KS.

Med Care. 2014 Jul;52(7):594-601. doi: 10.1097/MLR.0000000000000151.

43.

Medical costs and productivity losses of cancer survivors--United States, 2008-2011.

Ekwueme DU, Yabroff KR, Guy GP Jr, Banegas MP, de Moor JS, Li C, Han X, Zheng Z, Soni A, Davidoff A, Rechis R, Virgo KS; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Jun 13;63(23):505-10.

44.

Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults.

Guy GP Jr, Yabroff KR, Ekwueme DU, Smith AW, Dowling EC, Rechis R, Nutt S, Richardson LC.

Health Aff (Millwood). 2014 Jun;33(6):1024-31. doi: 10.1377/hlthaff.2013.1425.

45.

Is provider type associated with cancer screening and prevention: advanced practice registered nurses, physician assistants, and physicians.

Kepka D, Smith A, Zeruto C, Yabroff KR.

BMC Cancer. 2014 Mar 31;14:233. doi: 10.1186/1471-2407-14-233.

46.

Advanced practice registered nurses, physician assistants and cancer prevention and screening: a systematic review.

Smith AA, Kepka D, Yabroff KR.

BMC Health Serv Res. 2014 Feb 12;14:68. doi: 10.1186/1472-6963-14-68. Review.

47.

Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients.

Warren JL, Mariotto A, Melbert D, Schrag D, Doria-Rose P, Penson D, Yabroff KR.

Med Care. 2016 Aug;54(8):e47-54. doi: 10.1097/MLR.0000000000000058.

48.

Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies.

Cho H, Klabunde CN, Yabroff KR, Wang Z, Meekins A, Lansdorp-Vogelaar I, Mariotto AB.

Ann Intern Med. 2013 Nov 19;159(10):667-76. doi: 10.7326/0003-4819-159-10-201311190-00005.

PMID:
24247672
49.

Economic burden of cancer survivorship among adults in the United States.

Guy GP Jr, Ekwueme DU, Yabroff KR, Dowling EC, Li C, Rodriguez JL, de Moor JS, Virgo KS.

J Clin Oncol. 2013 Oct 20;31(30):3749-57. doi: 10.1200/JCO.2013.49.1241. Epub 2013 Sep 16.

50.

Comparing cancer care, outcomes, and costs across health systems: charting the course.

Lipscomb J, Yabroff KR, Hornbrook MC, Gigli A, Francisci S, Krahn M, Gatta G, Trama A, Ritzwoller DP, Durand-Zaleski I, Salloum R, Chawla N, Angiolini C, Crocetti E, Giusti F, Guzzinati S, Mezzetti M, Miccinesi G, Mariotto A.

J Natl Cancer Inst Monogr. 2013;2013(46):124-30. doi: 10.1093/jncimonographs/lgt011. No abstract available.

Supplemental Content

Loading ...
Support Center